Together with the observation that doxorubicin works in a cell cycle dependent fashion, while activation of PRKG1 is likely to work in a cell cycle independent fashion, suggests that activation of PRKG1 may be acting on cells in a different phenotype and state, i.e., slowly dividing sphere glioma cells, than doxorubicin. This evidence concerns the gene PRKG1 and central nervous system cancer.